Literature DB >> 17425484

Viruses in the treatment of malignant glioma.

Richard G Everson, Mathias Gromeier, John H Sampson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17425484     DOI： 10.1586/14737175.7.4.321

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN： 1473-7175            Impact factor:   4.618


× No keyword cloud information.
  5 in total

1.  The combined effects of oncolytic reovirus plus Newcastle disease virus and reovirus plus parvovirus on U87 and U373 cells in vitro and in vivo.

Authors:  Muhannad Alkassar; Barbara Gärtner; Klaus Roemer; Friedrich Graesser; Jean Rommelaere; Lars Kaestner; Isabelle Haeckel; Norbert Graf
Journal:  J Neurooncol       Date:  2011-05-24       Impact factor: 4.130

2.  Ultrastructural analysis of ICP34.5- herpes simplex virus 1 replication in mouse brain cells in vivo.

Authors:  Hina Mehta; Jacqueline Muller; Nancy S Markovitz
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

3.  Phase 1 clinical trial of intratumoral reovirus infusion for the treatment of recurrent malignant gliomas in adults.

Authors:  Kimberly P Kicielinski; E Antonio Chiocca; John S Yu; George M Gill; Matt Coffey; James M Markert
Journal:  Mol Ther       Date:  2014-02-20       Impact factor: 11.454

4.  Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumor-based orthotopic xenograft mouse models of pediatric glioma.

Authors:  Zhigang Liu; Xiumei Zhao; Hua Mao; Patricia A Baxter; Yulun Huang; Litian Yu; Lalita Wadhwa; Jack M Su; Adekunle Adesina; Lazlo Perlaky; Mary Hurwitz; Neeraja Idamakanti; Seshidhar Reddy Police; Paul L Hallenbeck; Richard L Hurwitz; Ching C Lau; Murali Chintagumpala; Susan M Blaney; Xiao-Nan Li
Journal:  Neuro Oncol       Date:  2013-05-07       Impact factor: 12.300

Review 5.  Diffuse glioma growth: a guerilla war.

Authors:  An Claes; Albert J Idema; Pieter Wesseling
Journal:  Acta Neuropathol       Date:  2007-09-06       Impact factor: 17.088
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.